Competitive Hormone Supplementation Is Shaping America’s Future Business Titans

Brian P. Hoover argues that hormone-altering drugs are shaping how American business leaders behave, with testosterone supplementation helping keep executives combative well into middle age. He cites male testosterone levels declining at about 1% per year and the number of U.S. testosterone replacement therapy patients tripling from 2001 through 2013. Hoover suspects that Jeff Bezos, Elon Musk and Sergey Brin may be using such drugs, though he says he has no access to their medical records. He also links cocaine to 1980s hostile takeovers and Adderall to the 2000s boom in credit derivatives.